POAI:NASDAQ, Predictive Oncology Inc.

POAI stock overview

Predictive Oncology Inc. (POAI:NASDAQ) closed at $5.95 on December 11, 2025, up 1.19% on the day. The stock trades 87.0% below its 52-week high of $45.90 and 53.4% above its 52-week low of $3.88. Predictive Oncology Inc. is part of the Health Care sector (Industrial Specialties).

Key figures

Price
$5.95
Day change
+1.19%
Volume
52,200
Average volume
105,906
Market cap
20M+
52-week range
$3.88 – $45.90
50-day average
$7.23
200-day average
$12.72

Price action over the past year

In 252 trading sessions since October 21, 2025, POAI closed higher on 17 days (7%). Its best day was December 19, 2025 (+21.16%) and its worst was December 5, 2025 (-22.19%). The stock moved 10% or more in a single session 8 times.

About Predictive Oncology Inc.

Precision Therapeutics Inc functions in the healthcare domain. It is a medical device company that develops and manufactures The STREAMWAY System, a solution for the collection and disposal of infectious fluids that result from surgical procedures and post-operative care. The Company distributes these products to hospitals, surgical centers and other medical facilities where bodily and irrigation fluids produced during surgical procedures must be contained, measured, documented and disposed of.

Similar stocks

Find more stocks like POAI with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.